SpectraCell's FIA™ is a clinically effective diagnostic tool for the prevention and management of chronic disease conditions. There is overwhelming evidence confirming that nutrient deficiencies have been shown to suppress immune function contributing to chronic disease process including cardiovascular disease, diabetes, arthritis and more!

The SpectaCell test is a patented tests for assessing the function of specific vitamins, minerals, antioxidants and other essential micronutrients within an individual's white blood cells (lymphocytes). The technology is referred to as a Functional Intracellular Analysis or FIA™, and is the industry's gold standard for evaluating nutritional status. Unlike traditional serum, hair, and urine tests, it provides a complete picture of an individual's functional intracellular nutritional status.

This detailed nutritional information opens a "window on intracellular function" and enables clinicians to develop appropriate interventions for patients who are pursuing lasting health.

About SpectraCell

SpectraCell Laboratories, Inc., is a specialized clinical testing laboratory company established in 1993 to commercialize a patented, groundbreaking technology, the Functional Intracellular Analysis™ (FIA™)

FIA™ was developed at the University of Texas, by the Clayton Foundation for Research, as a diagnostic blood test for helping clinicians assess the intracellular function of essential micronutrients. Since acquiring the rights to FIA™, SpectraCell has become the premier provider of tests for identifying subclinical nutritional deficiencies. Our laboratory and corporate headquarters are located in Houston, Texas. We serve the entire United States, and several foreign countries.

For more information about the company and the test, click here.